VSVeridiana Baldon dos Santos

Veridiana Baldon dos Santos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Veridiana Baldon dos Santos has a total of 166 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Percepção dos familiares de pacientes com COVID-19 sobre a internação em terapia intensiva adulto

    by Sofia Louise Santin Barilli, Anelise Kirst da Silva, Veridiana Baldon, Anelise Cristina Schmitz Franco, Lisiane Souza, Andréia Martins Specht

    Objective: To know the perception of family members of COVID-19 hospitalized patients about the period of hospitalization in an Adult Intensive Care Unit. Methodology: Descriptive and qualitative study with adult family members of patients with COVID-19 admitted to an Adult Intensive Care Unit of a tertiary public hospital in Porto Alegre (RS), Brazil. A sheet with sociodemographic data and a semi-structured questionnaire were used. The interviews were conducted between November and December/2020 by phone call and the sample was determined by data saturation. Bardin’s content analysis was used. Results: Nine family members aged between 23 and 56 years old participated. Predominated women, mostly daughters. The number of days in isolation ranged from 8 to 31. Five categories emerged: The Intensive Care Unit as a death sentence; The impact of a new disease; Family distance and exclusion; Support networks; The imminence of death. Conclusion: Hospitalizations due to COVID-19 in Intensive Care Unit were permeated by fear and anguish of family members, increased because it is a new and incurable disease. The need for isolation made physical contact impossible, impacting the understanding of the condition and the elaboration of mourning. The support of team healthcare, other family members and friends, faith and religiosity emerged as protective mechanisms. Anticipatory grief, fear of death without saying goodbye and multiple losses are central to grief. Emotional support for family members is essential, in order to promote psychological well-being and prevent psychological injuries and complicated grief.

  • Open Access

    Factors associated with mortality in critically ill patients with COVID-19

    by Rafaela dos Santos Charão de Almeida, André Klafke, Andresa Fontoura Garbini, Daniela dos Reis Carazai, Fernanda Costa dos Santos, Raquel Lutkmeier, Veridiana Baldon

    Background and objectives: COVID-19 is a life-threatening disease. Recognizing the main characteristics of the disease and its main complications will help future interventions, care, and management of health services since territorial and population diversities directly influence health outcomes. Our main objective is to describe the clinical characteristics, outcomes, and factors associated with mortality of patients with COVID-19 admitted to the intensive care unit of a public and tertiary hospital. Methods: Cohort study, conducted from March 1 to September 30, 2020. Poisson regression was performed to investigate the variables of hospital treatment as potential risk factors for in-hospital mortality. Results: Of the 283 eligible patients in this study, the hospital mortality rate was of 41.7% (n=118). The most common outcomes were acute respiratory distress syndrome, nosocomial infection, and septic shock. Factors independently associated with increased risk of death were age greater than 51 years old (RR=1.7, 95%CI=1.0-2.8), especially over 70 years old (RR=2.9, 95%CI=1.7-2.8), current smoker (RR=1.8, 95%CI=1.1-2.9), requiring the use of inotrope (RR=1.4, 95%CI=1.0-2.0), and presenting potassium greater than 5.0 mEq/l on admission (RR=1.3, 95%CI=1.0-1.7).


  • Frequency and burden of neurological manifestations upon hospital presentation in COVID-19 patients: Findings from a large Brazilian cohort

    by Milena Soriano Marcolino, Fernando Anschau, Luciane Kopittke, Magda Carvalho Pires, Izabela Guimarães Barbosa, Daniella Nunes Pereira, Lucas Emanuel Ferreira Ramos, Luís Fernando Israel Assunção, André Soares de Moura Costa, Matheus Carvalho Alves Nogueira, et al.


  • Open Access

    Frequency and burden of neurological manifestations in hospitalized patients with COVID-19: findings from a large Brazilian cohort

    by Milena Soriano Marcolino, Fernando Anschau, Luciane Kopittke, Magda Carvalho Pires, Izabela Guimarães Barbosa, Daniella Nunes Pereira, Renata Brant de Souza Melo, Luís Fernando Israel Assunção, André Soares de Moura Costa, Matheus Carvalho Alves Nogueira, et al.

    Background Scientific data regarding the prevalence of COVID-19 neurological manifestations and prognosis in Latin America countries is still lacking. Therefore, the study aims to understand neurological manifestations of SARS-CoV 2 infection in the Brazilian population and its association with patient outcomes, such as in-hospital mortality. Methods This study is part of the Brazilian COVID-19 Registry, a multicentric COVID-19 cohort, including data from 37 Brazilian hospitals. For the analysis, patients were grouped according to the presence of self-reported vs. clinically-diagnosed neurological manifestations and matched with patients without neurological manifestations by age, sex, number of comorbidities, hospital, and whether or not patients ha neurological underlying disease. Results From 7,232 hospitalized patients with COVID-19, 27.8% presented self-reported neurological manifestations, 9.9% were diagnosed with a clinically-defined neurological syndrome and 1.2% did not show any neurological symptoms. In patients with self-reported symptoms, the most common ones were headache (19.3%), ageusia (10.4%) and anosmia (7.4%). Meanwhile, in the group with clinically-defined neurological syndromes, acute encephalopathy was the most common diagnosis (10.5%), followed by coma (0.6%1) and seizures (0.4%). Men and younger patients were more likely to self-report neurological symptoms, while women and older patients were more likely to develop a neurological syndrome. Patients with clinically-defined neurological syndromes presented a higher prevalence of comorbidities, as well as lower oxygen saturation and blood pressure at hospital admission. In the paired analysis, it was observed that patients with clinically-defined neurological syndromes were more likely to require ICU admission (46.9 vs. 37.9%), mechanical ventilation (33.4 vs. 28.2%), to develop acute heart failure (5.1 vs. 3.0%, p=0.037) and to die (40.7 vs. 32.3%, p<0.001) when compared to controls. Conclusion Neurological manifestations are an important cause of morbidity in COVID-19 patients. More specifically, patients with clinically defined neurological syndromes presented a poorer prognosis for the disease when compared to matched controls.

  • Open Access

    Adult patients admitted to a tertiary hospital for COVID-19 and risk factors associated with severity: a retrospective cohort study

    by Veridiana Baldon dos Santos, Airton Tetelbom Stein, Sofia Louise Santin Barilli, Andresa Fontoura Garbini, Rafaela Charão de Almeida, Daniela dos Reis Carazai, Fernanda Costa dos Santos, Raquel Lutkmeier, Isadora Helena Greve, André Klafke, et al.

    COVID-19 is a disease whose knowledge is still under construction, high transmissibility, with no consensual treatment available to everyone. Therefore, the identification of patients at higher risk of evolving to the critical form of the disease is fundamental. The study aimed to determine risk factors associated with the severity of COVID-19 in adults patients. This is an observational, retrospective study from a cohort of adult patients with COVID-19 admitted to a public hospital from March to August 2020, whose medical records were evaluated. For the association of possible severity predictors, a Poisson regression was used. The primary outcome was the critical form of the disease (need for admission to the Intensive Care Unit and/or invasive mechanical ventilation). We included 565 patients: mostly men; 55.5% of those who progressed to the critical form of the disease were over sixty years old. Hypertension, diabetes mellitus and obesity were the most frequent comorbidities. There were 39.8% of patients who progressed to the critical form of the disease. The hospital mortality rate was 22.1%, and that of critical patients was 46.7%. The independent factors associated with the severity of the disease were obesity [RR = 1.33 (95% CI 1.07 to 1.66; p = 0.011)], SpO2/FiO2 ratio ≤ 315 [RR = 2.20 (95% CI 1.79 to 2.71; p = 0.000)], C-reactive protein > 100 mg/L [RR = 1.65 (95% CI 1.33 to 2.06; p = 0.000)], and lymphocytes < 1,000/µL [RR = 1.44 (95% CI 1.18 to 1.75; p = 0.000)]. Advanced age and comorbidities were dependent factors strongly associated with the critical form of the disease.


  • Open Access

    Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes

    by Israel Molina, Milena Soriano Marcolino, Magda Carvalho Pires, Lucas Emanuel Ferreira Ramos, Rafael Tavares Silva, Milton Henriques Guimarães-Júnior, Isaias José Ramos de Oliveira, Rafael Lima Rodrigues de Carvalho, Aline Gabrielle Sousa Nunes, Ana Lara Rodrigues Monteiro de Barros, et al.

    Chagas disease (CD) continues to be a major public health burden in Latina America. Information on the interplay between COVID-19 and CD is lacking. Our aim was to assess clinical characteristics and in-hospital outcomes of patients with CD and COVID-19, and to compare it to non-CD patients. Consecutive patients with confirmed COVID-19 were included from March to September 2020. Genetic matching for sex, age, hypertension, diabetes mellitus and hospital was performed in a 4:1 ratio. Of the 7018 patients who had confirmed COVID-19, 31 patients with CD and 124 matched controls were included (median age 72 (64–80) years-old, 44.5% were male). At baseline, heart failure (25.8% vs. 9.7%) and atrial fibrillation (29.0% vs. 5.6%) were more frequent in CD patients than in the controls (p < 0.05). C-reactive protein levels were lower in CD patients compared with the controls (55.5 [35.7, 85.0] vs. 94.3 [50.7, 167.5] mg/dL). In-hospital management, outcomes and complications were similar between the groups. In this large Brazilian COVID-19 Registry, CD patients had a higher prevalence of atrial fibrillation and chronic heart failure compared with non-CD controls, with no differences in-hospital outcomes. The lower C-reactive protein levels in CD patients require further investigation.


  • Open Access

    ABC2-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores

    by Milena S. Marcolino, Magda C. Pires, Lucas Emanuel F. Ramos, Rafael T. Silva, Luana M. Oliveira, Rafael L.R. Carvalho, Rodolfo Lucas S. Mourato, Adrián Sánchez-Montalvá, Berta Raventós, Fernando Anschau, et al.